Imfinzi (durvalumab) - AstraZeneca
BVAC-C - Cellid
Avastin (bevacizumab) - Roche
https://igcs2022.com/wp-content/uploads/sites/177/2022/09/IGCS22-E-Book-E-Poster-Trials-in-Progress.pdf
 
Chel Hun Choi1; Byoung-Gie Kim1; Jeong-Won Lee2; Tae-Joong Kim1; Yoo-Young Lee1; Joseph Noh2; Chi-Son Chang3; Sang Yong Song1; Duck Cho2; Byoung_Kwan Park3; Dae-Yeon Kim4; Ki Dong Kim5; Hee Seung Kim6; Jung-Yun Lee7; Myong Cheol Lim8; Insu Jeon9; Bo-Yeong Song9; Kwang-Soo Shin9; Wu-Hyun Kim9; Chang-Yuil Kang9
 
Sep 9, 2022
 
Prev Next